Ganymed Pharmaceuticals AG is a biopharmaceutical company with the mission of revolutionizing cancer treatment by developing a new class of therapeutic drugs called Ideal Monoclonal Antibodies (IMABs). IMABs are unique in that they are highly selective for proteins which are present on tumor cells, but do not bind to healthy cells. This unmatched tumor cell specificity makes IMABs cancer cell selective allowing them to efficiently kill tumor cells without harming normal healthy tissues. They can thus be administered at optimal dose and have a broad therapeutic window with reduced risks of side effects.

ImmunoFrontier, Inc. is a holding company that specializes in the research and development of cancer vaccines. It develops CHP cancer protein vaccines and multifunctional cancer DNA vaccines. The firm also establishes technology solutions for promoting the creation of cancer DNA vaccines and therapeutics for immune diseases. The company was founded by Shiku Hiroshi on October 5, 2004 and is headquartered in Tokyo, Japan.

The First Hospital of Jilin University, part of Jilin University, is a company headquartered in Changchun, China. The firm owns and operates hospital.

Cambridge University Technical Services Ltd., part of University of Cambridge, is a British company located in Cambridge. The firm provides consulting services. It was founded in 2006.

PersImmune is a clinical-stage immunotherapy company whose mission is to provide cancer patients with optimized immunotherapy that is personalized on the basis of their own unique tumor signature.

immatics is a biopharmaceutical company focused on the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors. The company's customized Adoptive Cell Therapies (ACTengine) and antibody-like TCR Bispecifics are the two main product classes in the pipeline (TCER). With a focus on particularly difficult-to-treat solid malignancies, each therapy modality has unique characteristics to create the desired therapeutic impact for patients at various disease stages and with various types of tumors. immatics biotechnologies was established in 2000 by Hans Rammensee, Harpreet Singh, and Steffen Walter in Tübingen, Baden-Wurttemberg.

Calyx Ventures, Inc. is an agricultural technology company, which engages in owning a portfolio of proprietary intellectual property with applications in crop enhancement. Its Cannigistics software platform is designed to enhance the efficiency and effectiveness of indoor agricultural operations and positions. The company was founded on June 10, 2008 and is headquartered in Vancouver, Canada.

SentoClone AB is a Swedish scientific research company developing SentoClone® - a patented method where the immune defense system is activated and strengthened to combat cancer.\nSentoClone is registered with the European Medicines Ageny, EMEA, as an SME (small and medium sized enterprises).\nSentoClone AB is a member of the IML, The Swedish Association for small and medium-sized companies active in R&D.\nSentoClone AB is owned by a number of venture capital firms, among them Stena Adactum AB, Sahltech i Göteborg AB and T-bolaget AB, together with founders Ola Winqvist and Magnus Thörn.

DKFZ Deutsche Krebsforschungszentrum is a German private company that operates as a cancer research center.

The Institute Pasteur is a private, non-profit foundation. Its mission is to help prevent and treat diseases, mainly those of infectious origin, through research, teaching, and public health initiatives.The Institut Pasteur is a research center of international renown ideally located in the very heart of Paris. Each year the institute hosts a multitude of scientific and medical conferences and meetings as well as events on a variety of themes.

Meiji Seika Pharma Co., Ltd. engages in the business of manufacture and distribution of pharmaceutical products. It also engages in the animal health business. The company was founded on October 9, 1916 and is headquartered in Tokyo, Japan.

Bioinfra Co., Ltd. is engaged in the business of research and development of medicine and chemical substances. The company was founded on May 23, 2007 and is headquartered in Suwon, South Korea.

Vitamin (Shanghai) Biotechnology Co., Ltd., established on 2019-06-17, The scope of business includes engaging in technology development in the professional field of biotechnology,Technical Services,technical consulting,technology transfer,Health Advisory,medical consultation;sell cosmetics. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Part of University of Arkansas System, Board of Trustees of The University of Arkansas is a company headquartered in Fayetteville, AR, that owns and operates radio stations.